CTOs on the Move

Integrated Recovery Products

www.irpusa.com

 
Integrated Recovery Products is a Costa Mesa, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million
  • www.irpusa.com
  • 1945 Placentia Ave Ste c1
    Costa Mesa, CA USA 92627
  • Phone: 949.548.8314

Executives

Name Title Contact Details

Similar Companies

CenterPlace Health

CenterPlace Health offers caring, affordable health care for residents of Sarasota County at three locations. We provide a range of primary health care services and work with a host of community partners to ensure integrated care to address the whole person. We accept Medicare, Medicaid and most private insurance plans, and we use an income-based formula to offer reduced rates for those who qualify. Everyone is expected to pay something, but no one is turned away.

ProviderLink

ProviderLink is a Cary, NC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

KaloBios

KaloBios is a biopharmaceutical company dedicated to helping the lives of patients with innovative therapies. Our mission is to improve the lives of cancer patients with innovative, Humaneered®, monoclonal antibodies. KaloBios` Humaneered® antibodies are next generation, customized antibodies designed to overcome challenges limiting today`s marketed antibody products. Using our expertise, our antibodies are customized to enhance a desired effect or reduce a possible undesired effect. Our pipeline is comprised of Humaneered® antibodies. These antibodies are being investigated in clinical development programs focused on treating cancer: KB004 (anti-EphA3) Humaneered® mAb to treat patients with hematologic malignancies, solid tumors, and their stem cells; currently enrolling patients with myelofibrosis and myelodysplastic syndrome in the company’s Phase 2 expansion portion of its Phase 1/2 clinical trial in hematologic malignancies; and KB003 (anti-GM-CSF) Humaneered® mAb that KaloBios intends to evaluate in oncology indications where GM-CSF may play a key role in such indications as chronic myelomonocytic leukemia (CMML). KaloBios intends to commence clinical evaluation of KB003 in this patient population beginning in the second half of 2015. We use a patient-targeted approach utilizing or developing a screen or diagnostic method to identify those patients most likely to benefit from our treatments.

BewellConnect Corp

BewellConnect Corp. is an ecosystem of connected devices and services that enhance care coordination.

MEDO USA

MEDO USA, Inc. is a Hanover Park, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.